Imatinib Terminated Phase 3 Trials for Chronic Myeloid Leukemia (CML) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01650805Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)